• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

F1000Res . SARS-CoV-2 Epidemic in India: Epidemiological Features and in silico Analysis of the Effect of Interventions

tetano

Editor, Senior Moderator
F1000Res


. 2020 Apr 30;9:315.
doi: 10.12688/f1000research.23496.1. eCollection 2020.
SARS-CoV-2 Epidemic in India: Epidemiological Features and in silico Analysis of the Effect of Interventions


Archisman Mazumder[SUP] 1 [/SUP], Mehak Arora[SUP] 1 [/SUP], Vishwesh Bharadiya[SUP] 1 [/SUP], Parul Berry[SUP] 1 [/SUP], Mudit Agarwal[SUP] 1 [/SUP], Priyamadhaba Behera[SUP] 2 [/SUP], Hemant Deepak Shewade[SUP] 3 4 [/SUP], Ayush Lohiya[SUP] 5 [/SUP], Mohak Gupta[SUP] 1 [/SUP], Aditi Rao[SUP] 1 [/SUP], Giridara Gopal Parameswaran[SUP] 1 [/SUP]



Affiliations

Abstract

Background: After SARS-CoV-2 set foot in India, the Government took a number of steps to limit the spread of the virus in the country. This included restricted testing, isolation, contact tracing and quarantine, and enforcement of a nation-wide lockdown starting 25 March 2020. The objectives of this study were to i) describe the age,gender distribution and mortality among COVID-19 patients identified till 14 April 2020 and predict the range of contact rate; and ii) predict the number of active COVID-19 patients after 40 days of lockdown. Methods: We used a cross-sectional descriptive design for first objective and a susceptible-infected-removed model for in silico predictions. We collected data from government-controlled and crowdsourced websites. Results: Studying age and gender parameters of 1161 Indian COVID-19 patients, the median age was 38 years (IQR, 27-52) with 20-39 year-old males being the most affected group. The number of affected patients were 854 (73.6%) men and 307 (26.4%) women. If the current contact rate continues (0.25-27), India may have 110460 to 220575 infected persons at the end of 40 days lockdown. Conclusion: The disease is majorly affecting a younger age group in India. Interventions have been helpful in preventing the worst-case scenario in India, but will be unable to prevent the spike in number of cases.

Keywords: COVID-19; Coronavirus; India; SIR model.
 
Back
Top Bottom